Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

IRWD holding history

Ironwood Pharmaceuticals Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IRWD overviewAll 13F holders of IRWDFull Q2 2026 holdings

Shares (Q2 2026)
26,848
Value
$113.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of IRWD by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202626,848$113.0K<0.1%−3,626−11.9%ReducedHolders
Q1 202630,474$107.0K<0.1%−5,841−16.1%ReducedHolders
Q4 202536,315$122.4K<0.1%+3,170+9.6%AddedHolders
Q3 202533,145$43.4K<0.1%−5,707−14.7%ReducedHolders
Q2 202538,852$27.9K<0.1%+1,007+2.7%AddedHolders
Q1 202537,845$55.6K<0.1%−12,359−24.6%ReducedHolders
Q4 202450,204$222.4K<0.1%+11,267+28.9%AddedHolders
Q3 202438,937$160.4K<0.1%+7,764+24.9%AddedHolders
Q2 202431,173$203.2K<0.1%−7,710−19.8%ReducedHolders
Q1 202438,883$338.7K<0.1%+2,917+8.1%AddedHolders
Q4 202335,966$411.5K<0.1%+4,703+15.0%AddedHolders
Q3 202331,263$301.1K<0.1%−348−1.1%ReducedHolders
Q2 202331,611$336.3K<0.1%+1,195+3.9%AddedHolders
Q1 202330,416$320.0K<0.1%−3,750−11.0%ReducedHolders
Q4 202234,166$423.3K<0.1%+2,580+8.2%AddedHolders
Q3 202231,586$328.0K<0.1%−162−0.5%ReducedHolders
Q2 202231,748$367.0K<0.1%−12,258−27.9%ReducedHolders
Q1 202244,006$553.0K<0.1%−11,105−20.2%ReducedHolders
Q4 202155,111$642.0K<0.1%+1,692+3.2%AddedHolders
Q3 202153,419$698.0K<0.1%−13,372−20.0%ReducedHolders
Q2 202166,791$860.0K<0.1%+1,875+2.9%AddedHolders
Q1 202164,916$726.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.